Premium
Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir? Authors' reply
Author(s) -
Banerjee D.,
Reddy K. R.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13586
Subject(s) - ombitasvir , paritaprevir , dasabuvir , medicine , ritonavir , contraindication , ribavirin , gastroenterology , hepatorenal syndrome , decompensation , cirrhosis , virology , hepatitis c virus , pathology , viral load , virus , alternative medicine , antiretroviral therapy